Data for stable formulation of steroid hormone receptor-targeted liposomes for cancer therapeutics  by Sharma, Priyanka et al.
Contents lists available at ScienceDirect
Data in Brief
Data in Brief 7 (2016) 428–431S
M
T
http://d
2352-34
(http://c
DOI
n Corr
E-mjournal homepage: www.elsevier.com/locate/dibData ArticleData for stable formulation of steroid hormone
receptor-targeted liposomes
for cancer therapeutics
Priyanka Sharma a, Rajkumar Banerjee b,
Kumar Pranav Narayan a,n
a Department of Biological Sciences, Birla Institute of Technology and Science Pilani, Hyderabad Campus,
Telangana 500078, India
b Biomaterials Group, CSIR-Indian Institute of Chemical Technology, Hyderabad, Telangana 500007, Indiaa r t i c l e i n f o
Article history:
Received 8 December 2015
Received in revised form
23 December 2015
Accepted 6 January 2016
Available online 27 February 2016
Keywords:
Steroid hormone
Liposomes
Lipoplexes
Anti-cancer gene
Transfection
Cytotoxicityx.doi.org/10.1016/j.dib.2016.01.003
09/& 2016 Published by Elsevier Inc. This
reativecommons.org/licenses/by/4.0/).
of original article: http://dx.doi.org/10.1016
esponding author. Tel.: þ91 40 6630 3568.
ail address: pranav@hyderabad.bits-pilani.aa b s t r a c t
A detailed description of steroid hormone ligand containing lipo-
somes and their stability has been given. Liposomes were com-
plexed with β-gal DNA and used to transfect cancer and non-
cancer cells. The stability of the liposomes and lipoplexes were
analysed using dynamic light scattering and DNA-binding gel
images. The formulations were used to assess the delivery of
anticancer gene, p53 in cancer cells. The dataset consists of DNA-
binding gel images, transfection, cytotoxicity and reverse tran-
scriptase PCR images.
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Value of the data
 Targeting diseased tissue/organ is important as most of the therapies lead to toxic effects on
normal tissues.
 The method can be used for stable cationic liposome preparation and efﬁcient transfection of cells.
 The data presents a novel way to treat receptor linked diseases.1. Data
The liposomal formulation contains mineralocorticoid receptor speciﬁc ligand, spironolactone
(hence the name SP for the targeted formulation) alongside the cationic lipid DODEAC and co-lipid
cholesterol. The size and potential i.e. stability of the liposomes were done using dynamic light
scattering at 0 day, after 4 days, 8 days and 12 days as shown in Tables S1 & S2. The stability of the
complexes were analysed by DNA-binding studies after 30 min, 4 h and 24 h of complex formation
(Fig. S2). The targeted liposomes(SP) and non-targeted liposomes (DO) were used to transfect cells of
both cancer (Fig. S1) and non-cancer origin. The transfection efﬁciency was observed after down-
regulation of the receptor with antagonist. The cells were down-regulated with mineralocorticoid
receptor speciﬁc MRsiRNA and the transfected with the lipoplexes to see the effect of receptor down-
regulation on transfection efﬁciency and cytotoxicity (Figs. S3 & S4).2. Experimental design, materials and methods
2.1. Preparation of Liposomes
Liposomes were prepared by the method described by [1]. Thin lipid ﬁlms were prepared by
drying the chloroform solution of 1 mM of DODEAC, 1 mM of cholesterol and three different con-
centrations of spironolactone i.e. 1 mM, 0.75 mM and 0.50 mM for three different liposomal formulation
i.e. 1:1:1, 1:1:0.75, 1:1:0.50 under a gentle stream of nitrogen and dried in vacuum for at least 4 h. It
was hydrated with 1 ml of sterile water overnight and then ﬁrst vortexed to remove any adhering
lipid ﬁlm, then subjected to a low intensity bath sonication for 15 min at room temperature and
ﬁnally probe sonication for 2 min using a constant duty cycle and output control magnitude of 2–3
Branson Soniﬁer 450.
2.2. Preparation of lipoplex and its treatment to cells
The lipid-DNA complex or lipoplex was prepared according to the protocol described by [5].
Brieﬂy, for in vitro studies related to toxicity and gene transfection studies, liposomes were serially
diluted in serum free media in ﬁnal volume of 50 ml and to it ﬁxed amounts of pDNA (0.3 mg/well of
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DNA were maintained as 1:1,2:1, 4:1 and 8:1. The mixtures were shaken in room temperature for
15 min following which 10% serum containing media (200 ml) were added to each mixture. Finally,
100 ml of resulting solution was then added to triplicate wells of cell containing 96-well plate. For RT-
PCR and western blot studies, the amount of pDNA used per well in 6-well plates was 2 mg and was
lipoplexed in a cationic lipid to DNA(7) charge ratio of 4:1.
2.3. Gel retardation of lipoplexes
The DNA binding ability of the cationic lipids were assessed by gel retardation assay on a 1%
agarose gel. 0.3 μg of pCMV- SPORT-β-gal was complexed with cationic lipids (1:1:0.75, molar ratios
were mixed with DNA at ﬁnal charge ratios of 8:1, 4:1, 2:1 and 1:1) in a total volume of 25 μL in Hepes
buffer, pH 7.4 and incubated at room temperature for 20–25 min. 4 μL of 6X loading buffer (0.25%
bromo phenol blue, 40% sucrose) was added to it and 20 μL of the resultant solution was loaded in
each well. The lipoplexes were run on 1% agarose gel, electrophoresed at 80 V for approximately 2 h
and the DNA bands were visualized by ultraviolet illumination. To check the stability at different time
points, lipoplexes were run on 1% agarose gel after 4 h and 24 h of complex formation (Fig. S2).
2.4. Determination of Zeta potential, particle size, and polydispersity index of liposomes
Values of the Zeta potential of liposomes indirectly reﬂect vesicle surface net charge and can
therefore be used to evaluate the extent of interaction of the liposomal surface cationic charges with
the anionic charges of DNA. The average particle size and the polydispersity of the particle-size
distribution of the liposomes were determined by Zeta sizer. Zeta potential is an indirect measure-
ment of the vesicle surface charge, and it can be used to evaluate the extent of interaction of the
liposomal surface cationic charges with the anionic charges of DNA [2–4]. To check the stability of the
liposomes, size and potential of the liposomes were checked every 4 days.
2.5. Gene transfections with β-gal plasmid
Cells were seeded at a density of 10,000 cells per well in a 96-well plate usually 18–24 h before
transfection. Transfection of cell was performed by method described by [1]. 0.3 mg of β-gal (diluted to
50 ml with plain DMEM) was complexed with varying amount of cationic liposomes (diluted to 50 ml
with plain DMEM) for 15–20 min. The molar ratios (lipid:DNA) were 8:1, 4:1, 2:1, 1:1. After formation
of lipoplexes, 200 ml of DMEM containing 10% FBS (CMIX) was added to the resulting lipoplexes for
triplicate experiments. Cells were washed with phosphate buffer saline (PBS), pH 7.4 (1100 ml) and
then treated with lipoplex (100 ml). After incubation of the cells at a humiﬁed atmosphere containing
5% CO2 at 37 °C for 4 h, the media was completely removed and 100 ml of DMEM containing 10%FBS
(CMIX) were added to the cells. The reporter gene activity was assayed after 48 h. The media were
completely removed from the wells and the cells were lysed with 50 ml of 1X lysis buffer (0.1% NP-40)
for 25–30 min. The cell lysates were assayed by taking the β-galactosidase readings and comparing
the protein content of them with that of BSA.
For RU486 and Eplerenone pretreated experiments, cells were treated with RU486 and Eplerenone
(in dimethyl sulphoxide) at a ﬁnal concentration of 100 mmol/lt for 2 h [5]. Cells were incubated at a
humiﬁed atmosphere containing 5% CO2 at 37 °C. Media were removed and the cells were washed
with PBS (1100 ml). The cells were subsequently treated with the lipoplexes and reporter gene assay
was performed according to the above-mentioned procedure. The transfection values were reported
as the average values of the triplicate experiment performed in the same plate on the same day. To
verify reproducibility, each transfection experiment was performed at least 4 times.
2.6. Cytotoxicity studies
Cytotoxicities of the liposomes were evaluated by the 3-(4, 5-dimethylthiazol-2-yl)2, 5-
diphenyltetrazolium bromide (MTT) reduction assay [6]. Brieﬂy, cells were seeded at a density of
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triplicate wells. Cells were treated with respective liposomes for 48 h. Following the termination of
experiment cells were washed and promptly assayed for viability using MTT. Results were expressed
as percent viability¼[A550 (treated cells)-background/A550 (untreated cells)-background]100.Acknowledgments
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